Refine by Content Type
Refine by Year
Choose Sites to Search:
FDA Paclitaxel Safety Panel Preview
An interview with FDA CDRH representatives discussing the upcoming advisory panel meeting to review concerns and current data on paclitaxel-eluting device use.
By Kenneth Cavanaugh, PhD, and Misti Malone, PhD
Current Considerations on Real-World Evidence Use in FDA Regulatory Submissions
Examples and decision making from the Center for Devices and Radiological Health's Peripheral Interventional Devices Branch.
By Eleni Whatley and Misti Malone
SPEED: A New Initiative in Real-World PAD Evidence Evaluation
An overview of the FDA's new multistakeholder project to support real-world evidence evaluation for devices aimed at treating peripheral artery disease.
By Misti Malone, PhD
Creating CLI Teams
The VIVA Physicians' Vascular Leaders Forum offers guidance on core competencies and quality measures for establishing multidisciplinary CLI care teams.
By John H. Rundback, MD; Tony S. Das, MD; Peter A. Schneider, MD; and Michael R. Jaff, DO; on behalf of the VLF participants
Interventional Oncology: Precision in Practice
By Ripal Gandhi, MD, FSVM, and David M. Liu, MD, FRCPC, FSIR
Highlights From the VIVA Vascular Leaders Forum on Paclitaxel Safety
Points of consensus, contention, and paths forward.
Highlights From ACC
ELVO in the Big Apple: How Stroke Teams Coordinate Efficient Care in a Gridlocked Metropolis
Utilizing models of stroke transfer to improve onset-to-treatment times for stroke patients.
By Daniel Wei, BS, and Johanna T. Fifi, MD
Venous Issues Relative to CLI
Do arterial and venous disease overlap in patients with tissue loss?
By Jose I. Almeida, MD, FACS, RPVI, RVT, and Cristal Boatright, MMS, PA-C